title: Regional differences in the force-frequency relation of human left ventricular myocardium in mitral regurgitation: implications for ventricular shape.
abstract: Sphericalization of the left ventricular (LV) chamber shape in patients with mitral regurgitation (MR) contributes to increased LV wall stress and energy consumption. On the basis of previous observations, we hypothesized the existence of regional differences in the force-frequency relation (FFR) within the LV that may contribute to its shape. Accordingly, in the present study, we assessed regional variation in the FFR in patients undergoing surgery for chronic, nonischemic MR with class II-III heart failure symptoms and related our findings to the in vivo LV shape. FFRs (steady-state isometric twitches, 0.2-3.4 Hz, 37 degrees C) were evaluated in MR myocardium from the LV subepicardial free wall (MR-FW) and papillary muscle (MR-PM) and from the subepicardial free wall in coronary artery bypass graft patients with normal LV contraction patterns [nonfailing (NF)]. Ascending slope, optimal stimulation frequency, and maximal twitch tension of the FFR were depressed in MR-FW and MR-PM compared with NF (P < 0.05). FFR depression was greater in MR-PM than in MR-FW. Between 107 and 134 beats/min, twitch tension became weaker in MR-PM, whereas it increased in MR-FW. Elevation of intracellular cAMP with forskolin eliminated FFR depression in MR-FW but not in MR-PM. MR-PM also had a 35% lower myosin heavy chain content and slowed twitch kinetics. In MR patients, the echocardiographic end-diastolic LV shape (end-diastolic eccentricity index = long axis/short axis) correlated with the ratio of ascending FFR slopes such that the end-diastolic eccentricity index increased 10% per 15% increase in slope ratio (r = 0.88, P = 0.01). These regional differences in the frequency dependence of contractility between the free wall and papillary myocardium may contribute to changes in LV shape in MR as well as during exercise.
authors.affiliation: Department of Molecular Physiology and Biophysics, University of Vermont, Burlington, Vermont 05405, USA.
authors.forename: Louis A
authors.initials: LA
authors.lastname: Mulieri
authors.forename: Marc D
authors.initials: MD
authors.lastname: Tischler
authors.forename: Barbara J
authors.initials: BJ
authors.lastname: Martin
authors.forename: Bruce J
authors.initials: BJ
authors.lastname: Leavitt
authors.forename: Frank P
authors.initials: FP
authors.lastname: Ittleman
authors.forename: Norman R
authors.initials: NR
authors.lastname: Alpert
authors.forename: Martin M
authors.initials: MM
authors.lastname: LeWinter
mesh_terms: D005576:Colforsin / Q000494:pharmacology; D003971:Diastole / Q000187:drug effects / Q000502:physiology*; D004699:Endocardium / Q000502:physiology; D005260:Female; D006801:Humans; D066298:In Vitro Techniques; D008297:Male; D008875:Middle Aged; D008944:Mitral Valve Insufficiency / Q000473:pathology / Q000503:physiopathology*; D018995:Myosin Heavy Chains / Q000378:metabolism; D010496:Pericardium / Q000502:physiology; D013599:Systole / Q000187:drug effects / Q000502:physiology*; D016277:Ventricular Function, Left / Q000502:physiology*
chemical_list: D005576:Colforsin; D018995:Myosin Heavy Chains